FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065339964> ?p ?o ?g. }

• W2065339964 endingPage "h1554" @default.
• W2065339964 startingPage "h1554" @default.
• W2065339964 abstract "<b>Background:</b> Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an accurate tool for lymph node staging of non-small lung cancer (NSCLC). The majority of NSCLC patients require systemic chemotherapy during their treatment, with relatively poor responses. If one could predict chemotherapy response, ideally at the time of initial bronchoscopic examination, one could maximize therapeutic benefit while limiting toxicity. Thus, we aimed to investigate the feasibility of EBUS-TBNA for obtaining tissue samples from mediastinal lymph nodes that can be utilized for immunohistochemical analysis; and to stratify, molecularly-based, pN2-NSCLC patients into chemoresponsive and chemoresistant subgroups who might benefit from chemotherapy-tailorment. <b>Methods:</b> We examined the expression of six cell cycle-related proteins (pRb, cyclin D1, p16INK4A, p53, p21Waf1, Ki-67), in mediastinal lymph node specimens obtained by EBUS-TBNA, by immunohistochemistry in 36 pN2-NSCLC patients. We investigated their predictive role(s) for platinum-based chemotherapy response. <b>Results:</b> Immunostaining was feasible in all studied specimens. Univariate analysis revealed that p53 and p21Waf1 expressions were significantly related to the chemotherapy response (p=0.002, p=0.011, respectively). Multivariate logistic regression analysis revealed that only p53 overexpression was associated with poor response to chemotherapy (p=0.021). <b>Conclusions:</b> These results suggest that EBUS-TBNA is a feasible tool for obtaining mediastinal nodal tissue samples amenable for immunohistochemical analysis. Immunostaining of p53 in EBUS-TBNA guided specimens may be useful in predicting response to chemotherapy in N2-NSCLC patients, and help selection of those patients who might benefit from certain chemotherapeutic strategies." @default.
• W2065339964 created "2016-06-24" @default.
• W2065339964 creator A5002706321 @default.
• W2065339964 creator A5009972979 @default.
• W2065339964 creator A5011168003 @default.
• W2065339964 creator A5016489221 @default.
• W2065339964 creator A5030730584 @default.
• W2065339964 creator A5034393834 @default.
• W2065339964 creator A5035591781 @default.
• W2065339964 creator A5052878165 @default.
• W2065339964 creator A5053121427 @default.
• W2065339964 creator A5060938048 @default.
• W2065339964 creator A5061728924 @default.
• W2065339964 creator A5065914659 @default.
• W2065339964 creator A5072626302 @default.
• W2065339964 creator A5073745658 @default.
• W2065339964 creator A5078261291 @default.
• W2065339964 creator A5082847955 @default.
• W2065339964 date "2015-04-01" @default.
• W2065339964 modified "2023-10-12" @default.
• W2065339964 title "Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial" @default.
• W2065339964 cites W1559611661 @default.
• W2065339964 cites W1912692997 @default.
• W2065339964 cites W1988810265 @default.
• W2065339964 cites W2000709287 @default.
• W2065339964 cites W2002678874 @default.
• W2065339964 cites W2003671371 @default.
• W2065339964 cites W2006750738 @default.
• W2065339964 cites W2011699384 @default.
• W2065339964 cites W2043799760 @default.
• W2065339964 cites W2049865589 @default.
• W2065339964 cites W2052495674 @default.
• W2065339964 cites W2054478836 @default.
• W2065339964 cites W2067331760 @default.
• W2065339964 cites W2079174856 @default.
• W2065339964 cites W2091902215 @default.
• W2065339964 cites W2091951392 @default.
• W2065339964 cites W2092452128 @default.
• W2065339964 cites W2105604680 @default.
• W2065339964 cites W2128589740 @default.
• W2065339964 cites W2130460485 @default.
• W2065339964 cites W2132557460 @default.
• W2065339964 cites W2136886545 @default.
• W2065339964 cites W2148076737 @default.
• W2065339964 cites W2159483543 @default.
• W2065339964 cites W2160879811 @default.
• W2065339964 cites W2170297115 @default.
• W2065339964 cites W2314221612 @default.
• W2065339964 doi "https://doi.org/10.1136/bmj.h1554" @default.
• W2065339964 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4382115" @default.
• W2065339964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25832102" @default.
• W2065339964 hasPublicationYear "2015" @default.
• W2065339964 type Work @default.
• W2065339964 sameAs 2065339964 @default.
• W2065339964 citedByCount "25" @default.
• W2065339964 countsByYear W20653399642015 @default.
• W2065339964 countsByYear W20653399642016 @default.
• W2065339964 countsByYear W20653399642017 @default.
• W2065339964 countsByYear W20653399642018 @default.
• W2065339964 countsByYear W20653399642019 @default.
• W2065339964 countsByYear W20653399642020 @default.
• W2065339964 countsByYear W20653399642021 @default.
• W2065339964 countsByYear W20653399642022 @default.
• W2065339964 countsByYear W20653399642023 @default.
• W2065339964 crossrefType "journal-article" @default.
• W2065339964 hasAuthorship W2065339964A5002706321 @default.
• W2065339964 hasAuthorship W2065339964A5009972979 @default.
• W2065339964 hasAuthorship W2065339964A5011168003 @default.
• W2065339964 hasAuthorship W2065339964A5016489221 @default.
• W2065339964 hasAuthorship W2065339964A5030730584 @default.
• W2065339964 hasAuthorship W2065339964A5034393834 @default.
• W2065339964 hasAuthorship W2065339964A5035591781 @default.
• W2065339964 hasAuthorship W2065339964A5052878165 @default.
• W2065339964 hasAuthorship W2065339964A5053121427 @default.
• W2065339964 hasAuthorship W2065339964A5060938048 @default.
• W2065339964 hasAuthorship W2065339964A5061728924 @default.
• W2065339964 hasAuthorship W2065339964A5065914659 @default.
• W2065339964 hasAuthorship W2065339964A5072626302 @default.
• W2065339964 hasAuthorship W2065339964A5073745658 @default.
• W2065339964 hasAuthorship W2065339964A5078261291 @default.
• W2065339964 hasAuthorship W2065339964A5082847955 @default.
• W2065339964 hasBestOaLocation W20653399641 @default.
• W2065339964 hasConcept C126322002 @default.
• W2065339964 hasConcept C142724271 @default.
• W2065339964 hasConcept C143998085 @default.
• W2065339964 hasConcept C204232928 @default.
• W2065339964 hasConcept C2776256026 @default.
• W2065339964 hasConcept C2776694085 @default.
• W2065339964 hasConcept C2780849966 @default.
• W2065339964 hasConcept C4224716 @default.
• W2065339964 hasConcept C71924100 @default.
• W2065339964 hasConceptScore W2065339964C126322002 @default.
• W2065339964 hasConceptScore W2065339964C142724271 @default.
• W2065339964 hasConceptScore W2065339964C143998085 @default.
• W2065339964 hasConceptScore W2065339964C204232928 @default.
• W2065339964 hasConceptScore W2065339964C2776256026 @default.
• W2065339964 hasConceptScore W2065339964C2776694085 @default.
• W2065339964 hasConceptScore W2065339964C2780849966 @default.

• next